37107-81-6,MFCD00913267
Catalog No.:AA003MW3

37107-81-6 | 5-Vinylpyrimidine-2,4(1H,3H)-dione

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95% mix TBC as stabilizer
in stock  
$148.00   $104.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA003MW3
Chemical Name:
5-Vinylpyrimidine-2,4(1H,3H)-dione
CAS Number:
37107-81-6
Molecular Formula:
C6H6N2O2
Molecular Weight:
138.1240
MDL Number:
MFCD00913267
SMILES:
C=Cc1c[nH]c(=O)[nH]c1=O
NSC Number:
208961
Properties
Properties
 
Form:
Solid  
MP:
298-304˚C  
Storage:
-20 ℃;Inert atmosphere;  

Computed Properties
 
Complexity:
230  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
1  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
-0.2  

Downstream Synthesis Route

[1]Farina,Vittorio;Krishnan,Bala[JournaloftheAmericanChemicalSociety,1991,vol.113,#25,p.9585-9595]

[2]Farina,Vittorio;Krishnan,Bala[JournaloftheAmericanChemicalSociety,1991,vol.113,#25,p.9585-9595]

[1]Jones,A.Stanley;McClean,MichaelJ.;Slater,MartinJ.;Walker,RichardT.[JournaloftheChemicalSociety.PerkintransactionsI,1987,p.457-464]

[1]Jones,A.Stanley;Rahim,S.George;Walker,RichardT.;Clerq,EricDe[JournalofMedicinalChemistry,1981,vol.24,#6,p.759-760]

937-32-6    37107-81-6   
5-<2-(4-nitrophenylthio)>ethenyluracil 

[1]Farina,Vittorio;Firestone,RaymondA.[Tetrahedron,1993,vol.49,#4,p.803-810]

937-32-6    37107-81-6   
5-<2-(4-nitrophenylsulfinyl)>ethenyluracil 
 
5-<2-(4-nitrophenylsulfonyl)>ethenyluracil 

[1]Farina,Vittorio;Firestone,RaymondA.[Tetrahedron,1993,vol.49,#4,p.803-810]

[2]Farina,Vittorio;Firestone,RaymondA.[Tetrahedron,1993,vol.49,#4,p.803-810]

Literature

Title: Comparative pharmacology of oral fluoropyrimidines: a focus on pharmacokinetics, pharmacodynamics and pharmacomodulation.

Journal: British journal of cancer 20040816

Title: Single ascending dose tolerability, pharmacokinetic-pharmacodynamic study of dihydropyrimidine dehydrogenase inhibitor Ro 09-4889.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20040401

Title: Augmentation of the antitumor activity of capecitabine by a tumor selective dihydropyrimidine dehydrogenase inhibitor, RO0094889.

Journal: International journal of cancer 20030920

Title: Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine.

Journal: Bioorganic & medicinal chemistry letters 20030310

Title: Evaluation of 5-[1-(2-halo(or nitro)ethoxy-2-iodoethyl)]-2'-deoxyuridines as inhibitors of herpes simplex virus.

Journal: Journal of enzyme inhibition and medicinal chemistry 20030201

Title: Photochemical ligation of DNA 'words' for DNA computing.

Journal: Nucleic acids research. Supplement (2001) 20030101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:37107-81-6 Molecular Formula|37107-81-6 MDL|37107-81-6 SMILES|37107-81-6 5-Vinylpyrimidine-2,4(1H,3H)-dione
Catalog No.: AA003MW3
37107-81-6,MFCD00913267
37107-81-6 | 5-Vinylpyrimidine-2,4(1H,3H)-dione
Pack Size: 100mg
Purity: 95% mix TBC as stabilizer
in stock
$148.00 $104.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA003MW3
Chemical Name: 5-Vinylpyrimidine-2,4(1H,3H)-dione
CAS Number: 37107-81-6
Molecular Formula: C6H6N2O2
Molecular Weight: 138.1240
MDL Number: MFCD00913267
SMILES: C=Cc1c[nH]c(=O)[nH]c1=O
NSC Number: 208961
Properties
Form: Solid  
MP: 298-304˚C  
Storage: -20 ℃;Inert atmosphere;  
Complexity: 230  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 10  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 1  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: -0.2  
Downstream Synthesis Route
7486-35-3    696-07-1    37107-81-6 

[1]Farina,Vittorio;Krishnan,Bala[JournaloftheAmericanChemicalSociety,1991,vol.113,#25,p.9585-9595]

[2]Farina,Vittorio;Krishnan,Bala[JournaloftheAmericanChemicalSociety,1991,vol.113,#25,p.9585-9595]

108-98-5    37107-81-6    111375-52-1 

[1]Jones,A.Stanley;McClean,MichaelJ.;Slater,MartinJ.;Walker,RichardT.[JournaloftheChemicalSociety.PerkintransactionsI,1987,p.457-464]

77530-00-8    37107-81-6 

[1]Jones,A.Stanley;Rahim,S.George;Walker,RichardT.;Clerq,EricDe[JournalofMedicinalChemistry,1981,vol.24,#6,p.759-760]

937-32-6    37107-81-6   
5-<2-(4-nitrophenylthio)>ethenyluracil 

[1]Farina,Vittorio;Firestone,RaymondA.[Tetrahedron,1993,vol.49,#4,p.803-810]

937-32-6    37107-81-6   
5-<2-(4-nitrophenylsulfinyl)>ethenyluracil 
 
5-<2-(4-nitrophenylsulfonyl)>ethenyluracil 

[1]Farina,Vittorio;Firestone,RaymondA.[Tetrahedron,1993,vol.49,#4,p.803-810]

[2]Farina,Vittorio;Firestone,RaymondA.[Tetrahedron,1993,vol.49,#4,p.803-810]

Literature fold

Title: Comparative pharmacology of oral fluoropyrimidines: a focus on pharmacokinetics, pharmacodynamics and pharmacomodulation.

Journal: British journal of cancer20040816

Title: Single ascending dose tolerability, pharmacokinetic-pharmacodynamic study of dihydropyrimidine dehydrogenase inhibitor Ro 09-4889.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research20040401

Title: Augmentation of the antitumor activity of capecitabine by a tumor selective dihydropyrimidine dehydrogenase inhibitor, RO0094889.

Journal: International journal of cancer20030920

Title: Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine.

Journal: Bioorganic & medicinal chemistry letters20030310

Title: Evaluation of 5-[1-(2-halo(or nitro)ethoxy-2-iodoethyl)]-2'-deoxyuridines as inhibitors of herpes simplex virus.

Journal: Journal of enzyme inhibition and medicinal chemistry20030201

Title: Photochemical ligation of DNA 'words' for DNA computing.

Journal: Nucleic acids research. Supplement (2001)20030101

Building Blocks More >
5318-27-4
5318-27-4
6-Aminoindole
AA003N01 | MFCD02093959
68527-66-2
68527-66-2
6-Chloro-8-nitroquinoline
AA003N3F | MFCD00092380
902130-87-4
902130-87-4
6-Methoxy-3-pyridineacetic acid
AA003N6U | MFCD09924951
62643-56-5
62643-56-5
7-Aminoheptanoic acid hydrochloride
AA003NA6 | MFCD12405602
4790-79-8
4790-79-8
7-Methoxybenzofuran-2-carboxylic acid
AA003NDF | MFCD00060516
52417-22-8
52417-22-8
9-Aminoacridine hydrochloride monohydrate
AA003NH7 | MFCD00012663
1068-57-1
1068-57-1
Acethydrazide
AA003NKW | MFCD00007610
1592-31-0
1592-31-0
ALPHA,ALPHA,ALPHA,ALPHA-TETRABROMO-P-XYLENE
AA003NOM | MFCD00017857
2720-73-2
2720-73-2
Potassium O-pentyl carbonodithioate
AA003NTD | MFCD00059150
6996-92-5
6996-92-5
BENZENESELENINIC ACID
AA003NY5 | MFCD00002100
Submit
© 2017 AA BLOCKS, INC. All rights reserved.